Article

Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2

2022-07-03

Abstract excerpt

SARS-CoV-2 vaccines are effective at limiting disease severity, but effectiveness is lower among patients with cancer or immunosuppression. Effectiveness wanes with time and varies by vaccine type. Moreover, vaccines are based on the ancestral SARS-CoV-2 spike-protein that emerging variants may evade. Here, we describe a mechanistic mathematical model for vaccination-induced immunity, validate it with available cl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bb34ffc3-07c0-5427-b32c-5e4ffd697ab7
DOI: 10.1101/2022.06.30.22277076

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2DOI 10.1101/2022.06.30.22277076Read

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationSemantic proximity Read

Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationSemantic proximity Read

A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protectionSemantic proximity Read

Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity Read

Differential antibody dynamics to SARS-CoV-2 infection and vaccinationSemantic proximity Read

SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccinesSemantic proximity Read

Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platformSemantic proximity Read

Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccinationSemantic proximity Read

Integrative Modeling of SARS-CoV-2 Infection Dynamics to Inform COVID-19 Vaccination StrategiesSemantic proximity Read

SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunitySemantic proximity Read

Quantification of the IgG antibody response half-life for hybrid immunity to SARS-CoV-2Semantic proximity Read

Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profilingSemantic proximity Read